Abstract
陈园生,李黎,崔富强,邢文革,王璐,贾志远,周脉耕,龚晓红,王富珍,郑徽,罗会明,毕胜利,汪宁,杨维中,梁晓峰.中国丙型肝炎血清流行病学研究[J].Chinese journal of Epidemiology,2011,32(9):888-891
中国丙型肝炎血清流行病学研究
A sero-epidemiological study on hepatitis C in China
Received:May 10, 2011  
DOI:
KeyWord: 丙型肝炎  血清流行病学
English Key Word: Hepatitis C  Sero-epidemiology
FundProject:
Author NameAffiliationE-mail
CHEN Yuan-sheng Chinese Center for Disease Control and Prevention, Beijing 100050  
LI Li Chinese Center for Disease Control and Prevention, Beijing 100050  
CUI Fu-qiang Chinese Center for Disease Control and Prevention, Beijing 100050  
XING Wen-ge Chinese Center for Disease Control and Prevention, Beijing 100050  
WANG Lu Chinese Center for Disease Control and Prevention, Beijing 100050  
JIA Zhi-yuan Chinese Center for Disease Control and Prevention, Beijing 100050  
ZHOU Mai-geng Chinese Center for Disease Control and Prevention, Beijing 100050  
GONG Xiao-hong Chinese Center for Disease Control and Prevention, Beijing 100050  
WANG Fu-zhen Chinese Center for Disease Control and Prevention, Beijing 100050  
ZHENG Hui Chinese Center for Disease Control and Prevention, Beijing 100050  
LUO Hui-ming Chinese Center for Disease Control and Prevention, Beijing 100050  
BI Sheng-li Chinese Center for Disease Control and Prevention, Beijing 100050  
WANG Ning Chinese Center for Disease Control and Prevention, Beijing 100050  
YANG Wei-zhong Chinese Center for Disease Control and Prevention, Beijing 100050  
LIANG Xiao-feng Chinese Center for Disease Control and Prevention, Beijing 100050 liangxf@hotmail.com 
Hits: 5766
Download times: 2331
Abstract:
      目的 了解中国现阶段丙型肝炎病毒(HCV)感染现状。方法利用中国疾病预防控制中心“2006年中国乙型病毒性肝炎血清流行病学调查”保留的血清,以美国Murex 3.0和Ortho 3.0抗-HCV试剂为金标准建立标准血清库,筛选中国抗-HCV检测试剂,并用Chiron HCVRIBA 3.0复核检测结果结果 中国1~ 59岁人群抗-HCV调整流行率为0.43%(95%CI:0.33%~0.53%),男性和女性抗-HCV流行率分别为0.46%和0.40%,城市和农村人群经调整后均为0.43%。东、中和西部地区人群抗-HCV流行率分别为0.37%(95%CI:0.21%~0.53%)、0.67%(95%CI:0.40%~0.94%)和0.31% (95%CI:0.20% ~ 0.42%),3个地区人群抗-HCV流行率的差异无统计学意义;南方和北方地区人群抗-HCV流行率分别为0.29%(95%CI:0.21%~0.52%)和0.53%(95%CI:0.38% ~ 0.64%)。结论经综合性防治,目前中国属丙型肝炎低流行区。
English Abstract:
      Objective To better understand and measure the status of hepatitis C virus (HCV) infection, we conducted a sero-epidemiological study using the remaining blood samples and data of the nationwide survey of hepatitis B in Chinese residents which was carried out in 2006.Methods The anti-HCV reagent was screened out from the reagents by the HCV infection blood serum plate with anti-HCV positives or negatives. This plate recognized the Murex 3.0 and Ortho 3.0 reagents as gold standards. Anti-HCV in the blood samples were tested using this reagent and confirmed by Chiron HCV RIBA 3.0 reagents.Results Among the population aged 1 year to 59 year-olds, the overall prevalence rate of anti-HCV was 0.43% (95%CI: 0.33%-0.53% ), with the rates of anti-HCV among males and females as 0.46% and 0.40%, respectively. The prevalence rate of anti-HCV in urban area was 0.43%,and in rural area it was 0.43%. The prevalence rate of anti-HCV in the Eastern, Middle and Western areas were 0.37% (95% CI: 0.21%-0.53% ), 0.67% (95% CI: 0.40%-0.94% ) and 0.31% (95%CI: 0.20%-0.42% ) respectively. The prevalence rates of anti-HCV for the three areas did not show significant differences, statistically. The prevalence rate of anti-HCV in the South and North areas were 0.29%(95%CI:0.21%-0.52%) and 0.53% (95%CI:0.38%-0.64%)respectively.Conclusion Our data revealed that China was in the low prevalence area for hepatitis C infection and the results also suggested that the comprehensive measures for HCV control and prevention had been successfully achieved in the country.
View Fulltext   Html FullText     View/Add Comment  Download reader
Close